Danielle A Murphy (Danielle Murphy)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Locally Advanced

Endoplasmic Reticulum

Chemotherapy Induced

Epidermal Growth Factor Receptor

Top Venues

Cancer research communications

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study. Cancer research communications (2024)
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study. Cancer research communications 4 (6) (2024)
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study. Cancer research communications 4 (6) (2024)
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study. Cancer research communications 4 (6) (2024)
Jennifer M Giltnane, Katherine E Hutchinson, Thomas P Stricker, Luigi Formisano, Christian D Young, M Valeria Estrada, Mellissa J Nixon, Liping Du, Violeta Sanchez, Paula I Gonzalez Ericsson, Maria G Kuba, Melinda E Sanders, Xinmeng Jasmine Mu, Eliezer Van Allen, Nikhil Wagle, Ingrid A Mayer, Vandana Abramson, Henry Gόmez, Monica Rizzo, Weiyi Toy, Sarat Chandarlapaty, Erica L Mayer, Jason Christiansen, Danielle A Murphy, Kerry Fitzgerald, Kai Wang, Jeffery S Ross, Vincent A Miller, Phillip J Stephens, Roman Yelensky, Levi Garraway, Yu Shyr, Ingrid Meszoely, Justin M Balko, Carlos L Arteaga
Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance. Science translational medicine 9 (402) (2018)